Рет қаралды 49,056
The first cholesterol lowering drug to enter the market, Triparanol, was an unmitigated disaster and left a trail of human wreckage behind, even after it was pulled from the market.
It was replaced by statins, shown to cause cancer in dogs before they even reached the market, and surrounded by controversy ever since. To this day, independent researchers do not have access to the data which could reveal the truth about statins.